Target intelligence / Profile preview

Cell cycle progression protein S-phase checkpoint control protein

Molecular classification
Other (cell cycle regulatory process, not a single molecule), Not a defined molecular family (refers to a process or group of proteins)
01

Overview

The term "Cell cycle progression protein S-phase checkpoint control protein" does not refer to a single, well-defined molecule but rather describes a functional category encompassing multiple proteins that regulate the S-phase DNA damage checkpoint during cell division. The S-phase checkpoint is part of the broader network of cell cycle checkpoints that monitor DNA integrity and replication status before allowing cells to proceed through critical phases such as DNA synthesis and mitosis. Key molecules involved in these checkpoints include cyclin-dependent kinases (CDKs), cyclins, tumor suppressors like p53, and sensor/effector kinases such as ATM/ATR, which collectively ensure proper replication and prevent propagation of damaged DNA[1][2][3]. Disruption or mutation in these pathways is strongly associated with cancer development due to loss of genomic stability. However, there is no canonical single "S-phase checkpoint control protein," making this entry non-specific and incorrect as a therapeutic target. The G1/S transition is governed by checkpoints involving multiple regulatory proteins including cyclins, CDKs, Rb family members, E2F transcription factors, ATM/ATR kinases, Chk1/Chk2 kinases, p21CIP/WAF1 inhibitors activated by p53—all acting together rather than via one unique "checkpoint control" molecule[1][2]. In summary: This entry does not correspond to any recognized individual therapeutic target but instead refers broadly—and imprecisely—to several key regulators within the complex machinery controlling cell division fidelity.

Other names
S-phase checkpoint control proteinCell cycle progression proteinCheckpoint control proteinS-phase checkpoint regulator
02

Mechanism of action

Not applicable; mechanisms depend on the specific molecular targets within the S-phase checkpoint pathway (e.g., CDKs, p53, ATM/ATR kinases).

03

Biological functions

Cell cycle regulationDNA damage responseCell proliferation controlMaintenance of genomic integrity
04

Disease associations

Cancer (dysregulation leads to uncontrolled cell division)Other diseases related to cell cycle defects
05

Safety considerations

Not applicable for this entry; safety concerns would relate to targeting essential cell cycle regulators and risk of toxicity or secondary malignancies if misregulated.
06

Biomarkers

p53phosphorylated Rb

Beyond the preview

Go deeper on Cell cycle progression protein S-phase checkpoint control protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell cycle progression protein S-phase checkpoint control protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call